Can cannabinoids help with tremor from Parkinson's, MS, and other movement disorders?
Cannabinoid receptors are densely concentrated in brain areas controlling movement, but clinical evidence for tremor relief remains inconclusive.
Quick Facts
What This Study Found
This review examined the potential of cannabinoid-based compounds to treat tremor associated with Parkinson's disease, multiple sclerosis, Huntington's disease, and forms of ataxia. The basal ganglia and cerebellum, brain regions central to motor control, contain high densities of cannabinoid receptors.
Anecdotal reports from cannabis users have suggested symptom improvement, prompting formal research. However, controlled studies have produced mixed results. Some preclinical work shows cannabinoids modulating motor circuits through shared molecular pathways across these diseases.
The authors concluded that while the biological rationale is promising, clinical evidence has not yet demonstrated reliable tremor reduction. They called for expanded preclinical studies with different cannabinoid compounds, followed by controlled clinical trials.
Key Numbers
Cannabinoid CB1 receptors are found at high density in the basal ganglia and cerebellum. The review covered tremor across 4 major motor disorder categories. Results across existing studies were described as inconclusive.
How They Did This
The researchers conducted a narrative review of published literature on cannabinoid effects in tremor-related motor disorders. They examined preclinical and clinical studies across Parkinson's disease, multiple sclerosis, Huntington's disease, and cerebellar ataxia, focusing on shared molecular mechanisms.
Why This Research Matters
Tremor is one of the most disabling symptoms of movement disorders and current treatments often provide incomplete relief. If cannabinoids could be shown to reduce tremor through their action on motor control circuits, they could fill a significant gap in treatment options for millions of patients worldwide.
The Bigger Picture
The endocannabinoid system is deeply intertwined with motor function, which is why cannabis can affect coordination and movement. Understanding whether this system can be therapeutically targeted for tremor could open new treatment avenues. But the gap between anecdotal reports and rigorous clinical evidence remains wide.
What This Study Doesn't Tell Us
This is a narrative review, not a systematic review or meta-analysis, so study selection may not be comprehensive. Many of the studies reviewed were preclinical or uncontrolled. The authors noted that clinical trial data is largely absent for most tremor indications.
Questions This Raises
- ?Which specific cannabinoid compounds are most promising for different types of tremor?
- ?Could synthetic cannabinoids targeting specific receptors provide tremor relief without psychoactive effects?
- ?Why have clinical results lagged behind the preclinical promise?
Trust & Context
- Key Stat:
- High CB1 receptor density in basal ganglia and cerebellum
- Evidence Grade:
- Narrative review synthesizing preclinical and limited clinical data across multiple motor disorders.
- Study Age:
- Published in 2015. Newer clinical trial data may have emerged since.
- Original Title:
- Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?
- Published In:
- Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 12(4), 778-87 (2015)
- Authors:
- Arjmand, Shokouh(2), Vaziri, Zohreh, Behzadi, Mina(3), Abbassian, Hassan, Stephens, Gary J, Shabani, Mohammad
- Database ID:
- RTHC-00905
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Does cannabis reduce tremor?
Anecdotal reports suggest it might for some people, but controlled studies have not consistently confirmed tremor reduction. The evidence remains inconclusive as of this review.
Why would cannabinoids affect movement?
The brain regions that control movement, including the basal ganglia and cerebellum, contain high concentrations of cannabinoid receptors, making them responsive to both endogenous and plant-derived cannabinoids.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-00905APA
Arjmand, Shokouh; Vaziri, Zohreh; Behzadi, Mina; Abbassian, Hassan; Stephens, Gary J; Shabani, Mohammad. (2015). Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 12(4), 778-87. https://doi.org/10.1007/s13311-015-0367-5
MLA
Arjmand, Shokouh, et al. "Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?." Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2015. https://doi.org/10.1007/s13311-015-0367-5
RethinkTHC
RethinkTHC Research Database. "Cannabinoids and Tremor Induced by Motor-related Disorders: ..." RTHC-00905. Retrieved from https://rethinkthc.com/research/arjmand-2015-cannabinoids-and-tremor-induced
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.